Literature DB >> 22584631

Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?

Michael W Yeh1, James E Wiseman, Philip H G Ituarte, Jesse D Pasternak, Roy S Hwang, Bian Wu, In-Lu Amy Liu, Philip I Haigh.   

Abstract

OBJECTIVE: To determine parathyroidectomy (PTx) rates in patients who satisfy the consensus guidelines for surgical treatment of primary hyperparathyroidism (PHPT).
BACKGROUND: Surgery for PHPT is recommended for all symptomatic patients and select asymptomatic patients meeting established consensus criteria. Adherence to the consensus guidelines has not been examined systematically, because of inadequate information regarding patients managed nonoperatively.
METHODS: All nonuremic patients with PHPT during the period 1995-2008 were identified using the Kaiser Permanente-Southern California laboratory database, encompassing 3.5 million individuals annually. Multivariate logistic regression was used to examine predictors of PTx.
RESULTS: We found 3388 patients with PHPT, of whom 265 (8%) were symptomatic (nephrolithiasis). Nephrolithiasis was predictive of PTx (OR 2.94 vs asymptomatic), with 51% of symptomatic patients undergoing surgery. Among asymptomatic patients, the proportion meeting consensus criteria was 39% during the early period (1995-2002) and 51% during the late period (2003-2008). The PTx rate for these patients exceeded that for asymptomatic patients not meeting consensus criteria but remained low (early 44% vs 19%, P < 0.0001; late 39% vs 16%, P < 0.0001). The following individual criteria were predictive of PTx: calcium >11.5 mg/dL (OR 2.27), hypercalciuria (OR 3.28, P < 0.0001), and age < 50 years (OR 1.54, P < 0.0001). However, the absolute PTx rates associated with satisfaction of these criteria were in the 50% range. Bone density scores did not influence likelihood of PTx and renal impairment predicted against PTx (OR 0.35, P < 0.0001).
CONCLUSIONS: The consensus guidelines regarding PHPT have not been followed in our study population. PTx appears to be underutilized in both asymptomatic and symptomatic patients.

Entities:  

Mesh:

Year:  2012        PMID: 22584631     DOI: 10.1097/SLA.0b013e31824dad7d

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  The role of parathyroidectomy in JAK2 mutation negative polycythemia vera.

Authors:  Afif N Kulaylat; Eric E Jung; Brian D Saunders
Journal:  Int J Hematol       Date:  2014-09-11       Impact factor: 2.490

2.  Improving diagnostic recognition of primary hyperparathyroidism with machine learning.

Authors:  Yash R Somnay; Mark Craven; Kelly L McCoy; Sally E Carty; Tracy S Wang; Caprice C Greenberg; David F Schneider
Journal:  Surgery       Date:  2016-12-15       Impact factor: 3.982

3.  ASO Author Reflections: Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons.

Authors:  Courtney Balentine
Journal:  Ann Surg Oncol       Date:  2020-06-15       Impact factor: 5.344

4.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

5.  Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.

Authors:  Ammar Asban; Alex Dombrowsky; Reema Mallick; Rongbing Xie; James K Kirklin; Raymon H Grogan; David F Schneider; Herbert Chen; Courtney J Balentine
Journal:  Oncologist       Date:  2019-04-24

6.  Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Authors:  F Saponaro; F Cetani; A Repaci; U Pagotto; C Cipriani; J Pepe; S Minisola; C Cipri; F Vescini; A Scillitani; A Salcuni; S Palmieri; C Eller-Vainicher; I Chiodini; B Madeo; E Kara; E Castellano; G Borretta; L Gianotti; F Romanelli; V Camozzi; A Faggiano; S Corbetta; L Cianferotti; M L Brandi; M L De Feo; A Palermo; G Vezzoli; F Maino; M Scalese; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-04-03       Impact factor: 4.256

7.  BMD improvements after operation for primary hyperparathyroidism.

Authors:  Lars Rolighed; Peter Vestergaard; Lene Heickendorff; Tanja Sikjaer; Lars Rejnmark; Leif Mosekilde; Peer Christiansen
Journal:  Langenbecks Arch Surg       Date:  2012-11-07       Impact factor: 3.445

8.  The impact of patient age on practice patterns and outcomes for primary hyperparathyroidism.

Authors:  Whitney Sutton; Joseph K Canner; Jessica B Shank; Abbey L Fingeret; Shkala Karzai; Dorry L Segev; Jason D Prescott; Aarti Mathur
Journal:  Am J Surg       Date:  2022-03-19       Impact factor: 3.125

9.  Surgery or no surgery: What works best for the kidneys in primary hyperparathyroidism? A study in a multi-ethnic Asian population.

Authors:  Yu Kwang Donovan Tay; Joan Khoo; Manju Chandran
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

10.  Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines.

Authors:  Carolyn D Seib; Tong Meng; Insoo Suh; Robin M Cisco; Dana T Lin; Arden M Morris; Amber W Trickey; Electron Kebebew
Journal:  Surgery       Date:  2020-07-09       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.